Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial

Autor: Arina J ten Cate-Hoek, Elham E Amin, Annemieke C Bouman, Karina Meijer, Lidwine W Tick, Saskia Middeldorp, Guy J M Mostard, Marije ten Wolde, Simone M van den Heiligenberg, Sanne van Wissen, Marlène HW van de Poel, Sabina Villalta, Erik H Serné, Hans-Martin Otten, Edith H Klappe, Ingrid M Bistervels, Mandy N Lauw, Margriet Piersma-Wichers, Paolo Prandoni, Manuela A Joore, Martin H Prins, Hugo ten Cate, Martin R Nijziel, Mandy Lauw, Y Whitney Cheung, Marlène H W van de Poel, Valentina Vedovetto

Publikováno v: ten Cate-Hoek, A J, Amin, E E, Bouman, A C, Meijer, K, Tick, L W, Middeldorp, S, Mostard, G J M, ten Wolde, M, van den Heiligenberg, S M, van Wissen, S, van de Poel, M H W, Villalta, S, Serné, E H, Otten, H M, Klappe, E H, Bistervels, I M, Lauw, M N, Piersma-Wichers, M, Prandoni, P, Joore, M A, Prins, M H & ten Cate, H 2018, ' Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT) : A multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial ', The Lancet Haematology, vol. 5, no. 1, pp. e25-e33 . https://doi.org/10.1016/S2352-3026(17)30227-2
Lancet Haematology, 5(1), 25-33. ELSEVIER SCI LTD
The Lancet Haematology, 5(1), e25-e33. Lancet Publishing Group
Lancet Haematology, 5, 1, pp. 25-33
The Lancet Haematology, 5(1), 25-33. ELSEVIER SCI LTD
Lancet. Haematology, 5(1), e25-e33. Lancet Publishing Group
Lancet Haematology, 5, 25-33

Background: Therapy with elastic compression stockings has been the cornerstone for prevention of post-thrombotic syndrome for decades in patients after acute deep venous thrombosis. It is uncertain who benefits most from therapy, and what the optimu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20e61c2ee20b248472af435872ddaf74
https://doi.org/10.1016/s2352-3026(17)30227-2

Toll-like receptor 9 gene expression in the post-thrombotic syndrome, residual thrombosis and recurrent deep venous thrombosis: A case-control study

Autor: Marije ten Wolde, Arina J. ten Cate-Hoek, Simone J.H. Wielders, Elisabetta Castoldi, Hugo ten Cate, Y. Whitney Cheung, Henri M. H. Spronk, A.C. Bouman

Publikováno v: Thrombosis research, 140, 106-109. Elsevier Limited
Thrombosis Research, 140, 106-109. Elsevier Science

Objective Animal models suggest that toll-like receptor 9 (TLR9) promotes thrombus resolution after acute deep venous thrombosis (DVT). We hypothesized that TLR9 expression is lower in patients with post-thrombotic syndrome (PTS) and investigated the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3838c7f6e6b8bc05e4a40154d819da
https://doi.org/10.1016/j.thromres.2016.02.025

In vivoreversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate

Autor: Saskia Middeldorp, Stefano Barco, Joost C. M. Meijers, Barbara A. Hutten, Michiel Coppens, Y. Whitney Cheung

Publikováno v: British journal of haematology, 172(2), 255-261. Wiley-Blackwell

Four-factor prothrombin complex concentrate (PCC) 50 iu/kg is able to swiftly restore haemostatic parameters in healthy subjects on rivaroxaban. We hypothesized that lower dosages of PCC may be sufficient to restore normal haemostasis. In this double

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc8e70120ed844069621856d8478dc4b
https://doi.org/10.1111/bjh.13821

Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study

Autor: Morgan Jaffrelot, Marije Ten Wolde, Renée A. Douma, Menno V. Huisman, Paul L. den Exter, Olivier Thierry Rutschmann, Farès Moustafa, Pierre-Marie Roy, Josien van Es, Alessandra Principe, Pieter Willem Kamphuisen, A Trinh-Duc, Marc Philip Righini, Olivier Sanchez, Marco J. J. H. Grootenboers, Marc Durian, Y. Whitney Cheung, Guy Meyer, Catherine Le Gall, Franck Verschuren, Grégoire Le Gal, Klaas W Van Kralingen, Petra M. G. Erkens, Henri Bounameaux, Anja A. van Houten, Alexandre Ghuysen, Germa Hazelaar

Publikováno v: JAMA : the journal of the American Medical Association
Journal of the American Medical Association
Journal of the American Medical Association, American Medical Association (AMA), 2014, 311 (11), pp.1117-24. ⟨10.1001/jama.2014.2135⟩
JAMA (Journal of the American Medical Association), Vol. 311, No 11 (2014) pp. 1117-1124
Journal of the American Medical Association, 311(11), 1117-1124
JAMA-Journal of the American Medical Association, 311(11), 1117-1124. AMER MEDICAL ASSOC
JAMA, 311(11), 1117-1124. American Medical Association
JAMA-Journal of the American Medical Association, 311(11), 1117-1124. American Medical Association

International audience; IMPORTANCE: D-dimer measurement is an important step in the diagnostic strategy of clinically suspected acute pulmonary embolism (PE), but its clinical usefulness is limited in elderly patients. OBJECTIVE: To prospectively val

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f076aa605fef57b4dd403ff4c8f626

IN VIVO REVERSAL OF THE ANTICOAGULANT EFFECT OF RIVAROXABAN WITH 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE

Autor: Barbara A. Hutten, Stefano Barco, Michiel Coppens, Joost C. M. Meijers, Whitney Cheung, Saskia Middeldorp

Publikováno v: Journal of the American College of Cardiology. 63(12)

Rivaroxaban lacks a specific reversal agent. Fifty units/kg of 4-factor prothrombin complex concentrate (PCC, Cofact®) completely reversed the anticoagulant effect of rivaroxaban in healthy subjects (Eerenberg, Circulation 2011;124:1573). We hypothe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::254641633d927abac8e653576e2e337e